Borgia M, Sepe N, Brancato V, Costa G, Simone P, Borgia R, Lugli R
J Int Med Res. 1983;11(2):124-7. doi: 10.1177/030006058301100212.
Seventy-five patients affected by chronic constipation were treated for 4 weeks with an Ispaghula Husk preparation (Fibrolax), a bulk-forming laxative. Frequency, stool consistency, abdominal pain and signs of venous stasis improved after treatment. No important side-effect was recorded. Cholesterol, HDL-cholesterol and triglycerides did not show significant changes.
75名慢性便秘患者接受了4周的卵叶车前草种子外壳制剂(Fibrolax,一种容积性泻药)治疗。治疗后,排便频率、粪便稠度、腹痛和静脉淤滞体征均有所改善。未记录到严重副作用。胆固醇、高密度脂蛋白胆固醇和甘油三酯未显示出显著变化。